Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Huapont Life Science Co's Enterprise Value is ¥19,091 Mil.
Huapont Life Science Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ¥1,324 Mil. Therefore, Huapont Life Science Co's EV-to-EBIT ratio for today is 14.42.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Huapont Life Science Co (SZSE:002004) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Huapont Life Science Co's current Enterprise Value is ¥19,091 Mil.
Huapont Life Science Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,324 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Huapont Life Science Co's EV-to-EBITDA for today is:
Huapont Life Science Co's current Enterprise Value is ¥19,091 Mil.
Huapont Life Science Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,522 Mil.
Huapont Life Science Co's current Enterprise Value is ¥19,091 Mil.
Huapont Life Science Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥11,477 Mil.
Huapont Life Science Co's current Enterprise Value is ¥19,091 Mil.
Huapont Life Science Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,363 Mil.
Huapont Life Science Co's current Enterprise Value is ¥19,091 Mil.
Huapont Life Science Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,751 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co Enterprise Value Related Terms
Huapont Life Science Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:002004 vs CTVA, CF, MOS: Enterprise Value Comparison
For the Agricultural Inputs subindustry, Huapont Life Science Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huapont Life Science Co Enterprise Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Huapont Life Science Co's Enterprise Value falls into.
Huapont Life Science Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Huapont Life Science Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huapont Life Science Co (SZSE:002004) has a Enterprise Value of ¥19,091 Mil as of Sep. 21, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Huapont Life Science Co and its competitors.
Is Huapont Life Science Co's Enterprise Value too high?
Huapont Life Science Co's current Enterprise Value is ¥19,091 Mil. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's Enterprise Value compare to CTVA and CF?
Huapont Life Science Co's Enterprise Value of ¥19,091 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Agriculture company?
A good Enterprise Value depends on the Agriculture industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Huapont Life Science Co and its competitors. Huapont Life Science Co's current Enterprise Value is ¥19,091 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.42, compared to a current price of ¥4.54 — trading 2.7% above its estimated fair value. The current Enterprise Value is ¥19,091 Mil. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current Enterprise Value is ¥19,091 Mil as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?
Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be overvalued.
The current stock price of ¥4.54 is trading 2.7% above its estimated GF Value™ of ¥4.42.
GuruFocus considers Huapont Life Science Co to be Fairly Valued.
Key valuation signals for SZSE:002004:
Enterprise Value: ¥19,091 Mil
GF Value™: ¥4.42 vs. price of ¥4.54 (2.7% above fair value)
No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score
Get the complete analysis for SZSE:002004
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002004 has been successfully added to your 
